How Pfizer’s alliance with Morgan State University prioritizes diversity in vaccine development

Pfizer (NYSE:PFE) and Morgan State University have unveiled a novel program known as the Doctor of Public Health (DrPH) Fellowship in Vaccines Medical Development. A central aim of the program is to foster diversity in vaccine development. 

In particular, the two-year DrPH program aims to increase the number of minority scholar-practitioners involved in vaccine development. In addition, the initiative will offer fellows training and networking opportunities to pave the way for leadership roles in the biopharma industry. 

The program officially launched today. 

Ronika Alexander-Parrish

Ronika Alexander-Parrish, a clinical scientist at Pfizer and founding director of the DrPH Fellowship, said the idea came out of brainstorming that began in the early days of the COVID-19 pandemic, which highlighted healthcare inequity. 

Alexander-Parrish said the company’s leadership embraced her vis…

Read more
  • 0